Status:
UNKNOWN
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
Lead Sponsor:
Lawrence Livermore National Laboratory at University of California
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
50-70 years
Phase:
PHASE2
Brief Summary
RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat. The amount of heterocyclic amines in the diet may affect prostate cancer screening results and the ri...
Detailed Description
OBJECTIVES: * Estimate dietary heterocyclic amine (HA) exposure in African American men who use HA-forming meats and cooking methods. * Correlate dietary HA exposure with prostate-specific antigen an...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- African American male
- No previous diagnosis of prostate cancer
- Desires prostate cancer screening as a routine preventative medical service
- PATIENT CHARACTERISTICS:
- Lives in or near Oakland, California
- Speaks English
- No medical or other disability (e.g., blindness, psychological dysfunction, or amputation) that would preclude study participation
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00354497
Start Date
March 1 2002
Last Update
September 20 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lawrence Livermore National Laboratory at University of California
Livermore, California, United States, 94550
2
Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States, 94609